Highlights of ASH in North America

Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.

Highlights of ASH in North America

Button - Play 66th ASH Annual Meeting and Exposition

Register Today

Highlights of ASH in North America attendees will connect with top hematology experts in person and learn how to apply the latest research to their own areas of expertise. Choose the location that best meets your schedule.

Chicago, Illinois | January 9-10, 2026 
New York, New York | January 9-10, 2026
Washington, D.C. | January 16-17, 2026
Seattle, Washington | January 30-31, 2026

Registration is now open!

Register Now View Registration Information

“Connecting with colleagues outside my particular area of focus within hematology has been very rewarding. Highlights of ASH is a great place to break out of my comfort zone and keep me up to date on the exciting advances in our field.”

Tyler W. Buckner, MD, MSc / University of Colorado School of Medicine
About Highlights Of ASH
Meeting Information

Program Schedule
Acknowledgments

About Highlights of ASH

Nothing compares to in-person connection. ASH strives to create opportunities for researchers and clinicians to interact with peers while learning about important developments in science, patient care, and education. The Highlights of ASH series offers convenient, streamlined hematology events held in multiple locations. No matter your role, Highlights of ASH programs are designed to ensure all attendees leave feeling more confident and better equipped for career success.

View Registration Information 

HOA_Speaker
HOA_NA_Meeting

Cutting-edge Research from Across Disciplines

Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.

 

Instant Insights

Ask questions and get feedback from top hematology experts in real time.

 

Real Advice You Can Use

Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.

 

Meet Experts in Your Field

Network with colleagues of all career stages and form connections in your field.

 

Earn CME credits

Attendees can earn continuing medical education (CME) credits for physicians, while non-physicians and other health care professionals may receive a Certificate of Participation.

Meeting Information

HOA_NA_Attendees
Registration
To begin the online registration process for Highlights of ASH, you will need your ASH username and password. If you do not have an ASH account, you can create one when you begin the registration process. See Additional Registration Information
HOA_NA_Hotel_Info
Hotel Information
ASH has secured discounted hotel rooms at each Highlights of ASH meeting locations. Please note that each meeting ends late Saturday afternoon. To ensure your safe and comfortable travel, ASH has secured rooms at the discounted rate through Saturday night. View Hotel Information

HOA_NA_Host_Satellite_Symposia
Satellite Symposia
Satellite Symposia are industry-sponsored, CME-accredited symposia that are offered in conjunction with ASH specialty meetings. They are independently organized and address topics not found in the ASH schedule and program. View Satellite Symposia Information
HOA_CME_MOC
CME and MOC Information
The American Society of Hematology (ASH) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. View CME and MOC Information
HOA_Become_an_Exhibitor
Become an Exhibitor
Plan now to exhibit at the Highlights of ASH to build visibility, develop and nurture customer relationships, and introduce new products and services. Exhibit at Highlights of ASH

HOA_NA_Accessibility
Accessibility Resources
ASH is committed to an inclusive meeting for all, focusing on accessibility for participants with disabilities. We encourage the accessibility community to travel to ASH events confidently, knowing support and resources are available.View Accessibility Resources

Program Schedule

This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, advanced practice providers, and hematopathologists. The following session topics correspond to the 2026 Highlights of ASH in North America and are subject to change. The program schedule is identical for all 2026 Highlights of ASH North America locations.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 p.m. Welcome and Introductions
12:00 p.m. Plasma Cell Disorder Personalization: How I Risk Stratify Patients and Sequence Therapies in Myeloma, AL Amyloidosis, and Their Precursors
Noura Elsedawy, MBBCh
University of Tennessee Health Science Center		 New York, NY
Washington, DC
Craig Hofmeister, MD, MPH
Emory University		 Seattle, WA
Ruben Niesvizky, MD
Weill Cornell Medicine		 Chicago, IL
12:45 p.m. Best of ASH in Transplantation Allogeneic Transplantation: Innovations in Donor Selection, GVHD Prophylaxis, MRD-Guided Strategies, and Transplant Care
Alexandra Gomez Arteaga, MD
Weill Cornell Medicine		 New York, NY
Marcos de Lima, MD
The Ohio State University		 Seattle, WA
Mark Levis, MD, PhD
Johns Hopkins University		 Washington, DC
Mariam Nawas, MD
University of Chicago Medical Center		 Chicago, IL
1:30 p.m. Advances in Pediatric Hematologic Malignancies: From Enhanced Risk Stratification to Novel Therapies
Rebecca Gardner, MD
St. Jude Children’s Research Hospital		 Chicago, IL
Rachel Rau, MD
University of Washington		 Seattle, WA
Rayne H. Rouce, MD
Baylor College of Medicine		 New York, NY
Washington, DC
2:15 p.m.  Panel Discussion 
2:45 p.m.  Coffee Break and Exhibits Open 
3:00 p.m. Advances in Aggressive Lymphoma
Manali Kamdar, MD, MBBS
University of Colorado		 Seattle, WA
John Kuruvilla, MD, FRCPC
Princess Margaret Cancer Centre		 New York, NY
Selay Lam, MD
Western University		 Chicago, IL
Craig Moskowitz, MD
University of Miami		 Washington, DC
3:45 p.m. How I Treat Acute Lymphoblastic Leukemia in 2025: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies
Emily Curran, MD
University of Cincinnati Cancer Center		 New York, NY
Rawan Faramand, MD
H. Lee Moffitt Cancer Center		 Washington, DC
John Molina, MD
Cleveland Clinic		 Seattle, WA
Lori Muffly, MD
Stanford University		 Chicago, IL
4:30 p.m. Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
Jia Ruan, MD, PhD
Weill Cornell Medicine		 New York, NY
Mazyar Shadman, MD, MPH
Fred Hutch / University of Washington		 Chicago, IL
Seattle, WA
Tanya Siddiqi, MD
City of Hope		 Washington, DC
5:15 p.m.  Panel Discussion 
5:45 p.m.  Highlights of ASH Day 1 Program Adjournment 
7:00 a.m. Registration and Exhibits Open
(Breakfast provided)
7:45 a.m. Welcome and Introductions
8:00 a.m. Frontiers in Bleeding Disorder Care: Novel Therapies and Clinical Practice
Tyler W. Buckner, MD, MSc
University of Colorado School of Medicine		 Washington, DC
Peter H. Cygan, MD
Penn State Health Milton S. Hershey Medical Center		 New York, NY
Kristina Maria Haley, DO
Oregon Health & Science University		 Seattle, WA
Lynn Malec, MD, MSc
Medical College of Wisconsin		 Chicago, IL
8:45 a.m. Advances in Thrombosis and Hemostasis: From Cancer-Associated VTE to Precision Risk Prediction
Joana M. Mack, MD
University of Arkansas for Medical Sciences		 Washington, DC
Chicago, IL
Anna L. Parks, MD
University of Utah		 Seattle, WA
Rachel P. Rosovsky, MD, MPH
Harvard Medical School		 New York, NY
9:30 a.m. Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology
Imo J. Akpan, MD
Columbia University Irving Medical Center		 New York, NY
Meera Chitlur, MD
Children's Hospital of Michigan		 Washington, DC
Allison P. Wheeler, MD, MSCI
University of Washington		 Chicago, IL
Seattle, WA
10:15 a.m.  Panel Discussion 
10:45 a.m.  Coffee Break and Exhibits Open 
11:00 a.m. Progress and Promise: Translating Innovation into Clinical Practice for MDS, MPN, and CML
Uma Borate, MD, MS
The Ohio State University		 Chicago, IL
Akriti Gupta Jain, MD, FACP
Cleveland Clinic		 New York, NY / Seattle, WA
Brandi Reeves, MD
University of North Carolina at Chapel Hill		 Washington, DC
11:45 a.m. The Future is Now: Advances in Acute Myeloid Leukemia
David Sanford, MD
UBC–BC Cancer Agency, Vancouver Coastal Health		 Seattle, WA
Caner Saygin, MD
University of Chicago		 Chicago, IL
Eunice S. Wang, MD
Roswell Park Comprehensive Cancer Center		 New York, NY
Washington, DC
12:30 p.m.   Panel Discussion
1:00 p.m.  Lunch with the Experts (All Speakers and Attendees) 
2:15 p.m. Novel Therapies and Clinical Outcomes in Hemoglobinopathies
Oyebimpe O. Adesina, MD, MS
University of California Davis School of Medicine		 Seattle, WA
Payal Desai, MD
Levine Cancer Institute, Atrium Health, Wake Forest University		 New York, NY
India Sisler, MD
Children's Hospital of Richmond at VCU		 Washington, DC
Madhav Vissa, MD
UCSF Benioff Children's Hospital		 Chicago, IL
3:00 p.m. Immune Cytopenias: Targeted, Tailored, Transformed
Juliana P. Botero, MD
Mayo Clinic		 New York, NY
Cyrus C. Hsia, MD
Western University, London Health Sciences Center		 Washington, DC
Caroline Piatek, MD
University of Southern California		 Seattle, WA
Senthil Sukumar, MD
Baylor College of Medicine		 Chicago, IL
3:45 p.m. Artificial Intelligence & Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care
Benjamin Chin-Yee, MD
Western University		 Chicago, IL
Barbara Lam, MD
Fred Hutchinson Cancer Center, University of Washington		 Seattle, WA
Ang Li, MD, MS
Baylor College of Medicine		 New York, NY
Rushad Patell, MD
Beth Israel Deaconess Medical Center		 Washington, DC
4:30 p.m.  Panel Discussions
5:00 p.m.  Closing Remarks and Adjournment 

Acknowledgments

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.

Highlights of ASH Steering Subcommittee

  • Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine 
  • Tyler Buckner, MD, MSc, University of Colorado Denver 
  • Payal C. Desai, MD, Atrium Health
  • Cyrus C. Hsia, MD, BSc, FRCPC, Western University
  • Manali Kamdar, MD, University of Colorado
  • Ang Li, MD, MS, Baylor College of Medicine
  • John C. Molina, MD, MEd, Cleveland Clinic
  • Ruben Niesvizky, MD, Weill Cornell Medicine
  • Rachel P. Rosovsky, MD, Harvard Medical School
  • Rayne H. Rouce, MD, Baylor College of Medicine
  • Eric Tse, MBBS, PhD, Hong Kong University

State Societies

We also wish to recognize the commitment of our State Societies in their support of the Highlights of ASH in North America meeting.

Gasco Logo Wide          Alabama Cancer Congress Logo

Corporate Support

  • AstraZeneca
  • Incyte Corporation
  • Lilly USA, LLC
  • Novartis Pharmaceuticals Corporation